Influenza hemagglutinin globular head (HA globular head)

The influenza hemagglutinin globular head is the membrane-distal domain of hemagglutinin, the major surface glycoprotein of influenza viruses. Hemagglutinin (HA) exists as a homotrimer, with each subunit composed of a globular head and a membrane-proximal stalk domain. The globular head contains the receptor binding site (RBS), which specifically recognizes sialic acid residues on host cell surfaces, determining viral tropism and host specificity. This domain is highly immunodominant and the principal target for strain-specific neutralizing antibodies elicited by infection or vaccination. However, it is also highly variable, undergoing frequent mutations that enable escape from host immunity, forming the basis for antigenic drift and shift in influenza viruses. Most commercially available influenza vaccines primarily induce antibody responses against the globular head. Universal vaccine and therapeutic antibody development increasingly targets conserved regions outside the head domain, recognizing the challenges posed by rapid evolution of the head's antigenic sites. The globular head of hemagglutinin is thus a critical therapeutic target in influenza infection; it is central to viral entry, immune recognition, and vaccine efficacy, but presents significant challenges due to its rapid antigenic evolution.

Other names

Hemagglutinin head domainHA headGlobular head domain of hemagglutininInfluenza virus hemagglutinin head

Neutralizing antibodies block the receptor-binding site on globular head, preventing virus attachment to host cells. Inhibition of viral entry by steric hindrance of HA-sialic acid interaction.